Follow
Andrea Zapater-Moros
Andrea Zapater-Moros
Estudiante predoctoral, Hospital Universitario La Paz
Verified email at estudiante.uam.es - Homepage
Title
Cited by
Cited by
Year
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
G Prado-Vázquez, A Gámez-Pozo, L Trilla-Fuertes, JM Arevalillo, ...
Scientific reports 9 (1), 1538, 2019
732019
Functional proteomics outlines the complexity of breast cancer molecular subtypes
A Gámez-Pozo, L Trilla-Fuertes, J Berges-Soria, N Selevsek, ...
Scientific Reports 7 (1), 10100, 2017
532017
Molecular characterization of breast cancer cell response to metabolic drugs
L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, M Díaz-Almirón, ...
Oncotarget 9 (11), 9645, 2018
222018
Urothelial cancer proteomics provides both prognostic and functional information
G de Velasco, L Trilla-Fuertes, A Gamez-Pozo, M Urbanowicz, ...
Scientific Reports 7 (1), 15819, 2017
212017
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
L Trilla-Fuertes, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros, ...
BMC cancer 19, 1-9, 2019
192019
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
L Trilla-Fuertes, A Gámez-Pozo, E López-Camacho, G Prado-Vázquez, ...
BMC cancer 20, 1-11, 2020
142020
Melanoma proteomics suggests functional differences related to mutational status
L Trilla-Fuertes, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros, ...
Scientific reports 9 (1), 7217, 2019
122019
Comprehensive characterization of the mutational landscape in localized anal squamous cell carcinoma
L Trilla-Fuertes, I Ghanem, J Maurel, G Laura, M Mendiola, C Peńa, ...
Translational Oncology 13 (7), 100778, 2020
112020
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer
A Zapater-Moros, A Gámez-Pozo, G Prado-Vázquez, L Trilla-Fuertes, ...
Oncotarget 9 (45), 27586, 2018
102018
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
K Rojas, L Trilla-Fuertes, A Gámez-Pozo, C Chiva, J Sepúlveda, L Manso, ...
ecancermedicalscience 13, 2019
92019
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
L Trilla-Fuertes, N Miranda, D Castellano, R López-Vacas, ...
PloS one 15 (2), e0229075, 2020
72020
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer
E López-Camacho, L Trilla-Fuertes, A Gámez-Pozo, I Dapía, ...
Biomedicine & Pharmacotherapy 149, 112844, 2022
62022
Bayesian networks established functional differences between breast cancer subtypes
L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, R López-Vacas, ...
PloS one 15 (6), e0234752, 2020
62020
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients
L Trilla-Fuertes, A Gámez-Pozo, M Díaz-Almirón, G Prado-Vázquez, ...
Future Oncology 15 (30), 3483-3490, 2019
52019
MiRNAs in renal cell carcinoma
J Miranda-Poma, L Trilla-Fuertes, E López-Camacho, A Zapater-Moros, ...
Clinical and Translational Oncology 24 (11), 2055-2063, 2022
42022
Genetic profile and functional proteomics of anal squamous cell carcinoma: Proposal for a molecular classification
L Trilla-Fuertes, I Ghanem, A Gamez-Pozo, J Maurel, G Laura, ...
Molecular & Cellular Proteomics 19 (4), 690-700, 2020
42020
Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
L Trilla-Fuertes, A Gámez-Pozo, MI Lumbreras-Herrera, R López-Vacas, ...
Cancers 14 (10), 2414, 2022
32022
Molecular characterization of triple negative breast cancer formaldehyde‐fixed paraffin‐embedded samples by data‐independent acquisition proteomics
S García‐Adrián, L Trilla‐Fuertes, A Gámez‐Pozo, C Chiva, ...
Proteomics 22 (3), 2100110, 2022
32022
Proteomics Characterization of Clear Cell Renal Cell Carcinoma
J Miranda-Poma, L Trilla-Fuertes, R López-Vacas, E López-Camacho, ...
Journal of Clinical Medicine 12 (1), 384, 2023
22023
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients
A Zapater-Moros, L Díaz-Beltrán, A Gámez-Pozo, L Trilla-Fuertes, ...
Metabolomics 19 (7), 60, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20